The Treatment Profiler application may only be used by healthcare professionals working in Israel that manage patients with Hepatitis C. The app requires a password that can be obtained at http://www.incivo.co.il/ by registered users of the web site. Some of the information provided may not be valid for residents of other countries due to variations in medical practice and drug approval. This...more

The Treatment Profiler application may only be used by healthcare professionals working in Israel that manage patients with Hepatitis C. The app requires a password that can be obtained at http://www.incivo.co.il/ by registered users of the web site. Some of the information provided may not be valid for residents of other countries due to variations in medical practice and drug approval.

This time-saving application provides healthcare professionals with easy to access information from key pivotal trials for INCIVO® (telaprevir) in the treatment of hepatitis C.

Rates of sustained virological response and recommended durations of treatment are presented for treatment-naïve and previously treated patient groups. The interactive features allow users to filter results by key patient characteristics providing fast access to relevant clinical data.

Easy-to-follow treatment algorithms including continuation and stopping rules are available for treatment-naïve and treatment experienced patients, with or without cirrhosis of the liver.

Data rates from you carrier may apply

Date of preparation : October 2013less